NT RCMP warn of fraudulent loan websites amid COVID-19 pandemic

Yellowknife, Northwest Territories – NT RCMP is warning residents of an increase of reporting to the Canadian Anti-Fraud Centre (CAFC) of scams related to fraudulent loan websites.

In a fraud bulletin, the CAFC states that fraudsters are using financial hardship many Canadians are facing during this pandemic to extort personal information through fake loan websites.

The CAFC report that these loan websites are designed to look like legitimate lending institutions.

Their fraudulent loan applications are used to collect personal information, which can result in identity theft and fraud. Once quickly approved, the fraudsters will request a fee to secure the loan. The victim never receives any money.

COVID-19 FRAUD SCAMS
COVID-19 FRAUD SCAMS

Here’s some tips on how to protect yourself:

In most provinces and territories, it is illegal for a company to request an upfront fee before you receive your loan. You should never send money first.

Beware of companies that offer guaranteed loans; even if you have bad credit or no credit.

Beware of instant approvals.

Do your research before you provide your personal information.

Contact your provincial/territorial consumer protection agency and/or financial regulator to confirm that a company is a legitimate lender.

End all contact if the company requests payment by email money transfer, money service businesses or pre-paid credit cards

For more information on Canada COVID-19 Economic Response Plan, please visit: https://www.canada.ca/en/department-finance/economic-response-plan.html.

Read more about loan scams on the Canadian Anti-Fraud Centre website.

If you think you or someone you know has been a victim of fraud, please contact the Canadian Anti-Fraud Centre at 1-888-495-8501 or report online at www.antifraudcentre.ca. NT RCMP also encourage to report to your local RCMP detachment.

Northwest Territories RCMP



Please help spread the word by "sharing" our reports on your social media accounts.



Drug Reports